These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8417334)

  • 1. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver.
    Sandgren EP; Luetteke NC; Qiu TH; Palmiter RD; Brinster RL; Lee DC
    Mol Cell Biol; 1993 Jan; 13(1):320-30. PubMed ID: 8417334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
    Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
    Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effects of c-myc and transforming growth factor alpha transgenes on liver tumor development in simian virus 40 T antigen transgenic mice.
    Enomoto A; Sandgren EP; Maronpot RR
    Vet Pathol; 1998 Jul; 35(4):283-91. PubMed ID: 9684972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
    Ohgaki H; Sanderson ND; Ton P; Thorgeirsson SS
    Cancer Lett; 1996 Aug; 106(1):43-9. PubMed ID: 8827045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the cooperative effects of transforming growth factor alpha and c-myc overexpression in rat liver epithelial cells.
    Presnell SC; Thompson MT; Strom SC
    Mol Carcinog; 1995 Aug; 13(4):233-44. PubMed ID: 7646762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
    Factor V; Oliver AL; Panta GR; Thorgeirsson SS; Sonenshein GE; Arsura M
    Hepatology; 2001 Jul; 34(1):32-41. PubMed ID: 11431731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
    Jakubczak JL; Chisari FV; Merlino G
    Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
    Thorgeirsson SS; Santoni-Rugiu E; Davis CD; Snyderwine EG
    Arch Toxicol Suppl; 1997; 19():359-66. PubMed ID: 9079223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
    Sanders S; Thorgeirsson SS
    Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
    Kao CY; Factor VM; Thorgeirsson SS
    Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
    Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
    Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.